Show simple item record

dc.contributor.authorAlbert, Michael
dc.date.accessioned2017-09-20T15:57:30Z
dc.date.available2017-09-20T15:57:30Z
dc.date.issued2017
dc.identifier.citationPereira, S. R. & Albert, M. (2017). Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms. Cochrane Database of Systematic Reviews, -(3), pp.14.
dc.identifier.other10.1002/14651858.CD012525
dc.identifier.urihttp://hdl.handle.net/20.500.12904/9804
dc.description.abstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
dc.description.abstractTo assess the effects of discontinuation compared with continued use of anticholinergic drugs prescribed for antipsychotic-induced extrapyramidal symptoms in people with schizophrenia and related disorders including schizophreniform disorder, delusional disorder, psychosis and schizoaffective disorder.
dc.description.urihttp://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012525/full
dc.formatFull text uploaded
dc.subjectSchizophrenia
dc.subjectDrug therapy
dc.titleAnticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms
dc.typeArticle
refterms.dateFOA2021-06-14T11:07:46Z
html.description.abstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
html.description.abstractTo assess the effects of discontinuation compared with continued use of anticholinergic drugs prescribed for antipsychotic-induced extrapyramidal symptoms in people with schizophrenia and related disorders including schizophreniform disorder, delusional disorder, psychosis and schizoaffective disorder.


Files in this item

Thumbnail
Name:
Pereira 2017 1-14.pdf
Size:
202.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record